Biologically and clinically significant cross-reactions may occur between the immunochemically similar capsule antigens of Haemophilus influenzae type b and Streptococcus pneumoniae type 6 by using counterimmunoelectrophoresis (CIE). In three cases of culture-proven S. pneumoniae type 6 disease, a false-positive H. influenzae type b CIE result was detected in a body fluid. Two of three cases were also positive when tested by CIE with pneumococcal omnisera. However, in one of the culture-proven cases of pneumococcal type 6 disease, the omniserum was negative and only the burro 132 H. influenzae type b antiserum demonstrated a positive precipitant reaction. In addition to the three case isolates, we evaluated nine blood or cerebrospinal fluid isolates of pneumococus type 6, using a variety of both species-and type-specific antisera, by CIE. Two burro antisera detected 12 of 12 (100%) of the S. pneumoniae type 6 strains. A rabbit H. influenzae type b antiserum did not detect any (0 of 12; 0%) of the S. pneumoniae type 6 strains evaluated. All (12 of 12; 100%) of the S. pneumoniae type 6 strains were detected with both rabbit omniserum (S. pneumoniae) and rabbit type 6 antiserum. Our data illustrate the importance of being aware of the immunologic cross-reactivity of the H. influenzae type b capsule with the pneumococcus type 6 capsule and the possibility of false-positive results with CIE when patient specimens are interpreted.
Counterimmunoelectrophoresis (CIE) is useful as a rapid means of detecting and identifying bacterial antigens in patient specimens of blood, urine, and cerebrospinal fluid (CSF). We report here the occurrence of immunologic cross-reactions among related antigens. Specifically, it has been documented that the capsular polysaccharide of Hae- mophilus influenzae type b is immunochemically similar to that of certain other antigens, including Streptococcus pneiumoniae type 6 (9) . We demonstrated that burro antiserum to H. influenzae type b cross-reacts with pneumococcus type 6 antigens with CIE. We report three cases in which patient specimens gave positive precipitin lines in CIE with both H. influenzae type b antiserum and omni (pneumococcal diagnostic antiserum). In all three cases, it was proven by culture that the patients were infected with pneumococcus type 6. These cases illustrate the importance of being aware of this cross-reaction and the possibility of false-positive results with CIE. ampicillin. Subsequently, the CSF culture grew S. pneumoniae type 6, which is susceptible to penicillin. Chloramphenicol therapy was discontinued, and the patient completed a course of therapy for pneumococcal meningitis.
Patient two, a 15-year-old female, had a 3-day history of headache, malaise, and nuchal rigidity prior to admission. On admission, analysis of the CSF showed 5,822 leukocytes per mm3, a protein level of 181 mg/dl, and a glucose level of 68 mg/dl (glucose in serum was 210 mg/dl). A Gram stain of CSF revealed leukocytes and gram-positive diplococci, and penicillin therapy was begun. Urine and CSF were both negative by CIE for pneumococcus, but the CSF was positive for H. inflienzae type b. Therapy was then changed to ampicillin and chloramphenicol. CSF and blood cultures grew S. pneumoniae. Ampicillin and chloramphenicol therapy was discontinued, and penicillin therapy was begun. The pneumococcus was then typed and discovered to be type 6. Patient three was a 17-month-old male with bronchopulmonary dysplasia, who was premature at birth and had a history of five previous hospital admissions. For a Isolates were tested after 4 h of incubation in brain heart infusion broth at 35°C and again after 18 h of incubation at 35°C in brain heart infusion broth.
and blood cultures grew only pneumococcus, so ampicillin and chloramphenicol therapy was discontinued, and therapy with penicillin was begun. The organism was typed by CIE and found to be type 6.
MATERIALS AND METHODS
Patient specimens included blood, CSF, and urine. The initial CIEs on patients one and three were done with CSF. Urine (concentrated 25 times with a Minicon B-15 filter) and CSF specimens from patient two were tested by CIE. Pneumococcus type 6 organisms isolated from patient specimens (blood or CSF) and all other isolates used in our experiments were typed by CIE at the time of isolation. All were frozen at -70°C in 1 ml of rabbit blood. All organisms were subcultured to sheep blood agar plates. The next day a brain heart infusion broth suspension was incubated for 4 h at 35°C, and this solution was tested against the antisera by CIE. H. influenzae type b antiserum and negative with omni serum. One specimen was positive with omni serum and negative with burro 132 H. influenzae type b antiserum. The fifth specimen was negative when tested against both burro 132 H. influenzae type b antiserum and omni serum, and the last specimen was tested with only burro 132 antiserum (omni serum was not tested) and was negative. Initially, therefore, three of six (50%) specimens from patients with documented S. pneumoniae 6 disease cross-reacted with burro 132 H. influenzae type b antiserum; one of six (14%) was positive with burro 132 H. influenzae type b antiserum only.
We evaluated a variety of antisera, both species and type-specific: rabbit omni serum (S. pneumoniae), burro 132 (H. influenzae type b), burro Dl (H. influenzae type b), rabbit H. influenzae type b, rabbit pneumococcal type 6, and normal (preimmunized) burro sera. These results are summarized in Table 1 6 disease associated with a biological false-positive H. influenzae type b CIE on a body fluid. In two of three cases, the pneumococcal omnisera also gave a positive result. However, in one of the culture-proven cases of pneumococcal type 6 disease, the omni sera gave a negative result, and only the burro 132 H. influenzae type b antiserum gave a positive result.
In our laboratory we have identified 127 isolates of S.
pneumoniae from blood and CSF cultured between January influenzae type b and S. pneumoniae) has been noted previously by the Quelling reaction (13, 15) . Tunwall has reported that 3 of 10 (30%) of S. pneumoniae type 6 organisms gave a positive capsular swelling reaction with anti-H. influenzae type b rabbit serum (13 In 1943, Neter referred to "the presence of antibodies directed against the specific soluble substance of this microorganism" when trying to explain the basis of the crossreaction between H. influenzae type b horse serum and S. pneumoniae type 6 (7). The pneumococcal type 6 organism has been shown to contain ribitol as the carbohydrate component of its polysaccharide capsule (8) . The type b polysaccharide of H. influenzae is also reported to be composed of polyribosylribitol phosphate (10, 12, 14) . Many other organisms, also containing ribitol, have been shown to cross-react with H. influenzae type b antisera. S. pneumoniae types 15, 29, and 34 cross-reacted in precipitin and capsular swelling tests (6, 7, 15) with H. influenzae type b antisera. Staphylococcus aureus, Bacillus pumilus, and Lactobacillus plantarum (1), in addition to Escherichia coli K100 and Streptococcus viridans, have been shown to give a precipitin halo when plated by the antiserum agar technique (3, 11) (agar containing H. influenzae type b antiserum). Staphylococcus aureus and Escherichia coli 075 were also shown to give a precipitin line when tested against rabbit H. influenzae type b antisera by CIE (4). Because ribose is a common capsular polysaccharide, the potential exists for cross-reactions to be found with many more encapsulated bacteria with a high-titer H. influenzae type b antisera. It should be noted that when latex particles coated with rabbit antibody to H. influenzae type b were used, one investigator found no cross-reactions using patient specimens (CSF, blood, urine) known to contain S. pneumoniae (5). It is not known whether any of the patients in that study had S. pneumoniae type 6 disease, because typihg of the organisms was not mentioned.
In our three patients, knowledge of the immunologic cross-reactivity of the H. influenzae type b capsule with the pneumococcus type 6 capsule was important in interpreting CIE results. Biologically and clinically significant crossreactions can occur when rapid diagnostic methods based on immunologic principles are used.
